Tevard Biosciences logo

Tevard Biosciences

Tevard Biosciences is developing novel gene therapy platforms to target Dravet Syndrome and other rare diseases with high unmet need. The company was founded in 2017 by Daniel Fischer and Warren Lammert, two parents of girls with Dravet Syndrome, and Harvey Lodish. Tevard’s SAB includes Bob Langer, David Liu, Lita Nelsen, Orrin Devinsky, and Ann Poduri.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Website
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
50 Carlson Ave, MA, 02459
Newton
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]